Detalhe da pesquisa
1.
Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy.
Ann Neurol
; 76(6): 802-12, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25273271
2.
The impact of sexual dysfunction on health-related quality of life in people with multiple sclerosis.
Mult Scler
; 20(5): 610-6, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23999609
3.
The Multiple Sclerosis Intimacy and Sexuality Questionnaire -- re-validation and development of a 15-item version with a large US sample.
Mult Scler
; 19(9): 1197-203, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23369892
4.
Interleukin-2/interleukin-2 antibody therapy induces target organ natural killer cells that inhibit central nervous system inflammation.
Ann Neurol
; 69(4): 721-34, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21425186
5.
Expansion of regulatory T cells via IL-2/anti-IL-2 mAb complexes suppresses experimental myasthenia.
Eur J Immunol
; 40(6): 1577-89, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20352624
6.
Statistical analysis of PML incidences of natalizumab-treated patients from 2009 to 2016: outcomes after introduction of the Stratify JCV® DxSelect™ antibody assay.
J Neurovirol
; 22(6): 880-881, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27730447
7.
Nicotinic attenuation of central nervous system inflammation and autoimmunity.
J Immunol
; 182(3): 1730-9, 2009 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19155522
8.
APOE ε4 is associated with exacerbation of cognitive decline in patients with multiple sclerosis.
Cogn Behav Neurol
; 24(3): 128-33, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21945984
9.
Impact of natalizumab on quality of life in a real-world cohort of patients with multiple sclerosis: Results from MS PATHS.
Mult Scler J Exp Transl Clin
; 7(2): 20552173211004634, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33948221
10.
Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study.
Adv Ther
; 38(7): 3724-3742, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34014549
11.
Smoking status over two years in patients with multiple sclerosis.
Neuroepidemiology
; 32(1): 72-9, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19001800
12.
Nicotine and inflammatory neurological disorders.
Acta Pharmacol Sin
; 30(6): 715-22, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19448649
13.
Induction of antigen-specific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled phase 1/2 trial.
Arch Neurol
; 64(10): 1407-15, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17698695
14.
Demyelinating disease and polyvalent human papilloma virus vaccination.
J Neurol Neurosurg Psychiatry
; 82(11): 1296-8, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20935322
15.
Disability Progression After Switching from Natalizumab to Fingolimod or Interferon Beta/Glatiramer Acetate Therapies: A NARCOMS Analysis.
Int J MS Care
; 18(5): 230-238, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27803638
16.
Correction to: Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study.
Adv Ther
; 38(7): 3743-3744, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34159559
17.
Radiologic MS disease activity during natalizumab treatment interruption: findings from RESTORE.
J Neurol
; 262(2): 326-36, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25381458
18.
Appropriateness of the Ilfeld Psychiatric Symptom Index as a screening tool for depressive symptomatology in persons with spinal cord injury.
J Spinal Cord Med
; 25(2): 129-32, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-12137217
19.
Improving resident research in physical medicine and rehabilitation: impact of a structured training program.
J Spinal Cord Med
; 27(5): 428-33, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15648795
20.
Autonomic dysreflexia: one more way EMS can positively affect patient survival.
JEMS
; 28(12): 46-51, 2003 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-14699347